1. From the Department for Neurodegenerative Diseases (M.S., T.G., R.K.), Hertie Institute for Clinical Brain Research, University of Tübingen, and DZNE, German Centre for Neurodegenerative Diseases, Tübingen, Germany; Stanford Prevention Research Center (J.P.A.I.), Department of Medicine and Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA; Department of Neurology (J.O.A.), St Olavs Hospital and NTNU Trondheim, Trondheim, Norway; Institute of Neurological...
2. Princess Alexandra Hospital, Brisbane , Site Investigator
3. Princess Alexandra Hospital, Brisbane, Site Investigator
4. Royal Brisbane and Women's Hospital Brisbane, Site Investigator
5. Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, QLD, Site Investigator
6. Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, QLD,Site Investigator
7. Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB; and Laboratory of Neurogenetics, Institute Born-Bunge; and University of Antwerp, Antwerpen, Site Investigator
8. Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB; and Laboratory of Neurogenetics, Institute Born-Bunge, and University of Antwerp, Antwerpen, Site Investiagtor
9. Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB; and Laboratory of Neurobiology, Institute Born-Bunge; and University of Antwerp; and Division of Neurology, University Hospital Antwerp, Antwerpen, Site Investigator
10. Memory Clinic and Division of Neurology, ZNA Middelheim, Antwerpen; and Division of Neurology, University Hospital Antwerp, Antwerpen, Site Investigator
11. Laboratory of Neurochemistry and Behavior, Institute Born-Bunge; and University of Antwerp; and Memory Clinic and Division of Neurology, ZNA Middelheim, Antwerpen, Site Investigator
12. Laboratory of Neurobiology, Institute Born-Bunge; and University of Antwerp; and Division of Neurology, University Hospital Antwerp, Antwerpen; Site Investigator
13. Tanz Centre for Research in Neurodegenerative Diseases, Department of Medicine, Division of Neurology, University of Toronto, ON, Canada, Site Investiagtor
14. Movement Disorders Centre, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, Site Investigator
15. Inserm U708, Paris, From the French Parkinson's Disease Genetics Study Group, Site Investigator
16. Inserm U708 E , Paris, From the French Parkinson's Disease Genetics Study Group, Site Investigator
17. Inserm U708 JC , Paris, From the French Parkinson's Disease Genetics Study Group, Site Investigator
18. Inserm U744, Lille, Site Investigator
19. Inserm UMRS775, Paris, Site Investigator
20. Inserm UMR837, Service de Neurologie et de Pathologie du Mouvement CHRU de Lille, Univ Lille Nord de France, Site Investigator
21. UMR837 Inserm-Univ Lille 2, CHRU de Lille, Site Investigator
22. Service de Neurologie et Pathologie du Mouvement, Clinique de Neurologie du CHU de Lille, Site Investigator
23. Department of Neurology, University Hospital Tuebingen, Site Investigator
24. Section of Clinical and Molecular Neurogenetics at the Department of Neurology, University of Lübeck, Site Investigator
25. Department of Neurology, University of Lübeck, Site Investigator
26. Department of Neurology, Goethe University Frankfurt am Main, Germany, Site Investigator
27. Department of Neurology, Faculty of Medicine, University of Thessaly and Institute of Biomedical Research & Technology, CERETETH, Larissa; Site Investigator
28. Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Site Investigator
29. Department of Neurology, Juntendo University School of Medicine, Tokyo, Site Investigator
30. Department of Neurology, and Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Site Investigator
31. Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Site Investigator
32. Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe, Japan, Site Investigator
33. The Dublin Neurological Institute at the Mater Misericordiae University Hospital, Clinical Investigator at the Conway Institute, University College Dublin, Ireland, Site Investigator
34. Department of Neurology, Royal Victoria Hospital, Belfast, Ireland, Site Investigator
35. IRCCS, Casa Sollievo della Sofferenza Hospital, Mendel Institute, San Giovanni Rotondo, Site Investigator
36. Mendel Institute, Casa Sollievo della Sofferenza Hospital, Rome, Site Investigator
37. Institute of Neurology, Catholic University, Rome, Site Investigator
38. Department of Neurology, Ospedale San Gerarado, Monza, Italy, Site Investigator
39. Department of Paediatrics, University of Milano-Bicocca, Monza, Site Investigator
40. Department of Neurology, Ospedale San Gerardo, Monza, Italy, Site Investigator
41. Institute of Neurological Sciences,National Research Council, Site Investigator
42. Institute of Neurological Sciences, National Research Council, Site Investigator
43. Department of Neurology, Seoul National University Hospital, Site Investigator
44. Department of Laboratory Medicine, Seoul National University Hospital, Site Investigator
45. Department of Neurology, University of Trondheim, Norway, Site Investigator
46. Department of Neurology, Aging, Degenerative and Cerebrovascular Disorders, Medical University of Silesia, Katowice; Site Investigator
47. Department of Neurology, Aging, Degenerative and Cerebrovascular Disorders, Medical University of Silesia, Katowice, Site Investigator
48. National Medical and Biomedical Research Councils, and the Duke-NUS Graduate Medical School, Singapore Millenium Foundation, Site Investigator
49. Department of Neuroscience, KarolinskaInstitutet, Stockholm, Site Investigator
50. Department of Neuroscience, KarolinskaInstitutet, Stockholm; Site Investigator
51. Department of Clinical Neuroscience, Karolinska University Hospital, Stockholm; Site Investigator
52. Department of Geriatric Psychiatry, Lund University; Site Investigator
53. Department of Neurology, Lund University Hospital, Department of Geriatric Psychiatry, Lund University, Site Investigator
54. Department of Neurology, Cushang Show-Chwan Hospital, Taiwan, Site Investigator
55. Department of Neurology, NorthShore Health Systems, Chicago, IL, Site Investigator
56. Department of Neurology, Mayo Clinic, Rochester, MN, USA, Site Investigator
57. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA, Site Investigator
58. Departments of Neurology and Health Sciences Research, Mayo Clinic, Rochester, MN, USA, Site Investigator
59. Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, Site Investigator
60. Division of Neuroscience, Mayo Clinic, Jacksonville, USA, Site Investigator
61. Department of Neurology, Mayo Clinic, Jacksonville, FL, Site Investigator